Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism

M Wyss, J Smeitink, RA Wevers, T Wallimann - Biochimica et Biophysica …, 1992 - Elsevier
Correspondence to: J. Smeitink, Wilhelmina Kinder/iekenhui~,. Nieuwegracht 137. 3512 LK
Utrecht, Netherland,,. Abbreviations: ANT, adenine nuclcotide tran~ locator: C'S. contact …

Mechanisms in protein O-glycan biosynthesis and clinical and molecular aspects of protein O-glycan biosynthesis defects: a review

S Wopereis, DJ Lefeber, E Morava… - Clinical …, 2006 - academic.oup.com
Background: Genetic diseases that affect the biosynthesis of protein O-glycans are a rapidly
growing group of disorders. Because this group of disorders does not have a collective …

[HTML][HTML] Autosomal recessive cutis laxa syndrome revisited

E Morava, M Guillard, DJ Lefeber… - European Journal of …, 2009 - nature.com
The clinical spectrum of the autosomal recessive cutis laxa syndromes is highly
heterogeneous with respect to organ involvement and severity. One of the major diagnostic …

The frequency of lysosomal storage diseases in The Netherlands

BJHM Poorthuis, RA Wevers, WJ Kleijer, JEM Groener… - Human genetics, 1999 - Springer
We have calculated the relative frequency and the birth prevalence of lysosomal storage
diseases (LSDs) in The Netherlands based on all 963 enzymatically confirmed cases …

Performance of near-infrared spectroscopy in measuring local O2 consumption and blood flow in skeletal muscle

MCP Van Beekvelt, WNJM Colier… - Journal of applied …, 2001 - journals.physiology.org
The aim of this study was to investigate local muscle O2consumption (muscV˙ o 2) and
forearm blood flow (FBF) in resting and exercising muscle by use of near-infrared …

Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder

WG Leen, J Klepper, MM Verbeek, M Leferink, T Hofste… - Brain, 2010 - academic.oup.com
Glucose transporter-1 deficiency syndrome is caused by mutations in the SLC2A1 gene in
the majority of patients and results in impaired glucose transport into the brain. From 2004 …

[PDF][PDF] Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man

K Tuschl, PT Clayton, SM Gospe, S Gulab… - The American Journal of …, 2012 - cell.com
Environmental manganese (Mn) toxicity causes an extrapyramidal, parkinsonian-type
movement disorder with characteristic magnetic resonance images of Mn accumulation in …

[HTML][HTML] Exome sequencing and the management of neurometabolic disorders

M Tarailo-Graovac, C Shyr, CJ Ross… - … England Journal of …, 2016 - Mass Medical Soc
Background Whole-exome sequencing has transformed gene discovery and diagnosis in
rare diseases. Translation into disease-modifying treatments is challenging, particularly for …

[HTML][HTML] SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder

V Cantagrel, DJ Lefeber, BG Ng, Z Guan, JL Silhavy… - Cell, 2010 - cell.com
N-linked glycosylation is the most frequent modification of secreted and membrane-bound
proteins in eukaryotic cells, disruption of which is the basis of the congenital disorders of …

[HTML][HTML] Multiple phenotypes in phosphoglucomutase 1 deficiency

LC Tegtmeyer, S Rust… - … England Journal of …, 2014 - Mass Medical Soc
Background Congenital disorders of glycosylation are genetic syndromes that result in
impaired glycoprotein production. We evaluated patients who had a novel recessive …